Skip Links
  • Skip to Navigation
  • Skip to Content
Clinical Guidelines Network
Personal tools
  • Create account
  • Log in
Navigation
  • Home
  • About
    • About the clinical guidelines
    • Declaring and dealing with competing interests
    • Frequently asked questions
    • Guideline journal articles
  • Cancer Council guidelines
    • Barrett's Oesophagus
    • Bowel cancer
      • Colorectal cancer
      • Surveillance colonoscopy
    • Endometrial cancer
    • Cervical cancer screening
    • Lung cancer
      • Lung cancer prevention & diagnosis
      • Lung cancer treatment
    • Prostate cancer
      • Advanced prostate cancer
      • PSA testing
    • Sarcoma
    • Skin cancer
      • Melanoma
      • Keratinocyte cancer (non-melanoma)
    • Pain management
    • Archive of CCA guidelines
  • COSA guidelines
    • Adolescents and Young Adult (AYA) guidelines
      • AYA cancer fertility preservation
      • AYA early cancer detection
      • AYA psychosocial management
    • Cancer therapy medication safety
    • Gastroenteropancreatic neuroendocrine tumours
    • Head & neck cancer nutrition
    • Teleoncology
  • National Cancer Prevention Policy
Melanoma
  • Foreword
  • Summary of recommendations
  • Identification and management of high-risk individuals
    • Identification and management of high-risk individuals – Introduction
    • Genetic determinants of high risk
    • Validated models for overall measurements of high risk
    • Interventions that benefit those at high risk of new primary melanomas
  • Diagnosis
    • Clinical features of melanoma
    • Diagnostic aids for melanoma
      • Diagnostic aids for melanoma
      • Dermoscopy
      • Sequential digital dermoscopy imaging
      • Automated instruments
      • Confocal microscopy
      • Skin surface imaging (total body photography)
  • Biopsy
    • Biopsy of suspicious lesion
    • Clinical information for the pathologist
  • Management of primary melanoma and lentigo maligna
    • Definitive margins for excision of primary melanoma
    • Melanoma in situ
    • Invasive melanomas
    • Sentinel node biopsy
    • Complete node dissection
    • Treatment for lentigo maligna
    • Primary desmoplastic and neurotropic melanomas
      • Primary desmoplastic neurotropic melanomas
      • Management of primary desmoplastic and neurotropic melanomas
      • Sentinel node biopsy for desmoplastic melanoma
  • Melanoma in children
  • Melanocytic tumour of unknown malignant potential
    • Management of MelTUMPs
    • Sentinel node biopsy for MelTUMPs
    • Excision margins in MelTUMPs
  • Management of melanoma in pregnancy
    • Pregnancy following a diagnosis of melanoma
    • Management of pregnant women with melanoma
    • Optimal management of pregnant women with melanoma
    • Continuation of HRT or oral contraceptive pill
  • Investigations and follow-up for melanoma patients
    • Investigations and follow-up – Introduction
    • Patients with stage I and stage II melanomas
    • Patients with in-transit/regional node disease (stage III)
    • Patients with stage IV melanoma
    • Follow up after initial definitive treatment
    • Ideal frequency and duration of follow-up
  • Treatment of satellite and in-transit metastases
  • Treatment of macroscopic nodal metastases
  • Treatment of melanoma brain metastases
    • Treatment of melanoma brain metastases
    • Systemic drug therapy for patients with brain metastases
    • Surgical treatment of brain metastases
    • Radiotherapy for patients with brain metastases
    • Summary of recommendations and practice points
  • Systemic therapy
    • Adjuvant systemic therapy – resected stage II and III melanoma
    • Systemic drug therapy – unresectable stage IIIC and IV melanoma
    • Immunotherapy
    • Targeted therapies (MEK and BRAF inhibitors)
    • Chemotherapy
    • Summary of recommendations and practice points
  • Radiotherapy
    • Radiotherapy for distant metastases
    • Radiotherapy following resection of involved lymph nodes
  • Management of mucosal melanoma
  • Management of ocular melanoma
  • Multidisciplinary care of melanoma patients
  • Appendices
    • Guideline development process
    • Working party members and contributors
    • List of clinical questions
    • Journal articles
    • Declarations of interest register
Social links
Page actions
  • View
  • Code
  • History
 
  • Refresh
  • What links here
  • Related changes
  • Special pages
  • Permanent link
  • Page information
  • Export to PDF
  • Browse properties

Declarations of interest register

From Clinical Guidelines Wiki
Clinical practice guidelines for the diagnosis and management of melanoma > Declarations of interest register







download icon Declaration of interest register

See also: A Code of Practice for Declaring and Dealing with Competing Interests

Last updated: 6 February 2019.

Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Guidelines:Melanoma/Conflict_of_interest_register&oldid=214357"